CHICAGO, Dec. 1, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) has announced the results of the 2022 member election for the 2023 Board of Directors as well as leadership positions in the Professional Communities. The Society will welcome six members to the Board of Directors […]
Financial
Broadview Ventures Appoints Michael Mendelsohn, MD to its Strategic Advisory Board
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced the appointment of Michael E. Mendelsohn, MD to its Strategic Advisory Board. Dr. Mendelsohn is an internationally recognized cardiovascular physician-scientist, industry research leader and biopharma executive with four decades of broad healthcare and medical experience. Dr. Mendelsohn is […]
Arrowhead Pharmaceuticals Reports Fiscal 2022 Year End Results
– Conference Call and Webcast Today, November 28, 2022 at 4:30 p.m. ET November 28, 2022 04:00 PM Eastern Standard Time PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal year ended September 30, 2022. The company is hosting a conference call today, November 28, […]
T-Heart Appoints Sarah Sorrel as Independent Board Member
PARIS–(BUSINESS WIRE)–T-Heart, a medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve specifically designed for tricuspid regurgitation, today announced it has appointed Sarah Sorrel as its first independent member of the Board of Directors. Sarah Sorrel has more than 30 years’ experience in medical device regulation […]
Dr. Sean Lyden Agrees to Assume the Role of Chief Medical Consultant and Join the VESTECK Scientific Advisory Board
WEST CHESTER, Pa., Nov. 28, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce that, Dr. Sean Lyden has agreed to assume the role of Chief Medical Consultant and also join the VESTECK Scientific Advisory Board. Dr. Lyden is currently the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold […]
Viz.ai Appoints Radiology Advisory Board to Advance Innovation
Leading experts to help shape the future of Viz.ai’s radiology strategy and platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support radiologists and patients. […]
Siemens Healthineers, Atrium Health Enter Multi-Year Value Partnership to Improve Health Care Capabilities, Access and Equity
The Value Partnership includes a capital commitment by Atrium Health to purchase Siemens Healthineers equipment of more than $140M Siemens Healthineers and Atrium Health will focus on workforce development and improving access to care in rural and underserved areas CHARLOTTE, N.C. & MALVERN, Pa.–(BUSINESS WIRE)–Siemens Healthineers and Atrium Health, a […]
Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology
Financing co-led by Vensana Capital and a Large, Global Medical Device Company Use of Proceeds to Advance Development of a Novel Catheter-based Solution for Mitral Regurgitation ATLANTA, Nov. 23, 2022 /PRNewswire/ — Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the […]
Medtronic reports second quarter fiscal 2023 financial results
Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes DUBLIN, Nov. 22, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022. Key Highlights Revenue of $7.6 billion decreased 3% […]
Tenaya Therapeutics Announces Closing of Public Offering
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today the closing of its previously announced underwritten public offering of […]
Recent
Merit Medical to Participate in Upcoming Investors Conferences in September
Medtronic Endurant™ stent graft system first and only to receive CE-mark for updated rupture labeling
SinglePass Device Achieves 100% Technical Success and Zero Clinically Significant Bleeding Events in Multicenter Study Published in the Journal of Vascular and Interventional Radiology
Popular
- No commented posts yet